Clinical Trials
98 trialsTRIDENT-1
Turning Point Therapeutics, Inc.
GRECCAR 5
University Hospital, Bordeaux
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
University of Florida
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
IDRX, Inc., a wholly owned subsidiary of GSK, LLC
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Pfizer
HYP-OP-RT
CHU de Quebec-Universite Laval
SECURE
Medtronic - MITG
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Brigham and Women's Hospital
ALTAIR
National Cancer Center Hospital East
G-PEC
Ukrainian Society of Clinical Oncology
Advancing Nursing Practices in Hospital Oncology Care
Memorial Sloan Kettering Cancer Center
ALLAN
Lund University Hospital
Post-Marketing Surveillance Study of OTEZLA
Amgen
ALFAOMEGA-R
IFOM ETS - The AIRC Institute of Molecular Oncology
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
Pfizer
Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios
Nanfang Hospital, Southern Medical University
ARROW
Hoffmann-La Roche
Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA
Thomas Jefferson University
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
STARS-GC09
The First Hospital of Jilin University
Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children With Leukemia
National Institute of Pediatrics, Mexico
Advanced Gastrointestinal Endoscopic Imaging
Stanford University
A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Theseus Pharmaceuticals
Point of Care 3D Ultrasound for Various Applications: A Pilot Study
Duke University
SGM-CBM
Leiden University Medical Center
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Kyowa Kirin Co., Ltd.
Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects
Mayo Clinic
Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.
Taipei Veterans General Hospital, Taiwan
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction
Catalysis SL
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
Catalysis SL
Endo-mmfi
Beijing 302 Hospital
Systems Biology of Gastrointestinal and Related Diseases
Viome
CanStem303C
Sumitomo Pharma America, Inc.
EXPLORING
The First Affiliated Hospital with Nanjing Medical University
Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )
Innovent Biologics (Suzhou) Co. Ltd.
ALpha-T
Hoffmann-La Roche
TEUS Registry
Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University
ICG-COLORAL
Oulu University Hospital
SEPTRALU
Sociedad Española de Medicina Nuclear e Imagen Molecular
ALTER-E005
Jiangxi Provincial Cancer Hospital
Sarcopenia and Physiology Assessments in Cancer Patients
University Hospital Southampton NHS Foundation Trust
Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
ALTER-C-002
Zhejiang University
CPET and Outcome After Oesophagogastric Cancer Surgery
University Hospital Southampton NHS Foundation Trust
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
State Scientific Centre of Coloproctology, Russian Federation
SOLAR
Taiho Pharmaceutical Co., Ltd.
Efficacy and Safety of Hou Gu Mi Xi in Patients With Spleen Qi Deficiency and Radical Gastrectomy for Gastric Cancer
Jiangxi University of Traditional Chinese Medicine
Evaluation of the Bowel Cleansing in Hospitalized Patients Using Pure-Vu System
Motus GI Medical Technologies Ltd
SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
TINGLE
Cedars-Sinai Medical Center